Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

AIMS Abdominal aortic aneurysm (AAA) is characterized by extensive aortic wall matrix degradation that contributes to the remodelling and eventual rupture of the arterial wall. Elastinolytic cathepsin S (Cat S) is highly expressed in human aneurysmal lesions, but whether it contributes to the pathogenesis of AAA remains unknown. METHODS AND RESULTS AAAs were induced in apolipoprotein E (ApoE) and Cat S compound mutant (Apoe(-/-)Ctss(-/-)) mice and in ApoE-deficient Cat S wild-type littermates (Apoe(-/-)Ctss(+/+)) by chronic angiotensin II infusion, and AAA lesions were analysed after 28 days. We found that Cat S expression increased significantly in mouse AAA lesions. The AAA incidence in Apoe(-/-)Ctss(-/-) mice was much lower than that in Apoe(-/-)Ctss(+/+) mice (10 vs. 80%). Cat S deficiency significantly reduced external and luminal abdominal aortic diameters, medial elastin fragmentation, and adventitia collagen content. Cat S deficiency reduced aortic lesion expression and the activity of matrix metalloproteinase (MMP)-2, MMP-9, and Cat K, but not the activity of other major cathepsins, such as Cat B and Cat L. Absence of Cat S significantly reduced AAA lesion media smooth muscle cell (SMC) apoptosis, lesion adventitia microvessel content, and inflammatory cell accumulation and proliferation. In vitro studies proved that Cat S helps promote SMC apoptosis, angiogenesis, monocyte and T-cell transmigration, and T-cell proliferation--all of which are essential to AAA pathogenesis. CONCLUSIONS These data provide direct evidence that Cat S plays an important role in AAA formation and suggest that Cat S is a new therapeutic target for human AAA.

[1]  J. Lindholt,et al.  Plasma Cathepsin S and Cystatin C Levels and Risk of Abdominal Aortic Aneurysm: A Randomized Population–Based Study , 2012, PloS one.

[2]  P. Libby,et al.  Cathepsin K Deficiency Reduces Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[3]  P. Libby,et al.  Cathepsin L Activity Is Essential to Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[4]  K. Horiuchi,et al.  Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development. , 2011 .

[5]  G. Shi,et al.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. , 2011, Pharmacology & therapeutics.

[6]  Y. Okada,et al.  Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm. , 2011, Cardiovascular research.

[7]  Robert J. Hinchliffe,et al.  Pathophysiology and epidemiology of abdominal aortic aneurysms , 2011, Nature Reviews Cardiology.

[8]  N. Rezaei,et al.  Defective T-cell Proliferation and IL-2 Production in a Subgroup of Patients with Coronary Artery Disease. , 2010, Iranian journal of allergy, asthma, and immunology.

[9]  M. Leinonen,et al.  Elevated MMP‐8 and Decreased Myeloperoxidase Concentrations Associate Significantly with the Risk for Peripheral Atherosclerosis Disease and Abdominal Aortic Aneurysm 1 , 2010, Scandinavian journal of immunology.

[10]  P. Libby,et al.  Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice. , 2010, The American journal of pathology.

[11]  Benjamin F. J. Verhaaren,et al.  The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms. , 2010, Journal of vascular surgery.

[12]  K. Hara,et al.  Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes. , 2010, Biochemical and biophysical research communications.

[13]  L. Beckers,et al.  Cathepsin K gene disruption does not affect murine aneurysm formation. , 2010, Atherosclerosis.

[14]  P. Holt,et al.  Review of Current Theories for Abdominal Aortic Aneurysm Pathogenesis , 2009, Vascular.

[15]  J. Jukema,et al.  Leukocyte Cathepsin S Is a Potent Regulator of Both Cell and Matrix Turnover in Advanced Atherosclerosis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[16]  David E. Anderson,et al.  In vitro induction of regulatory T cells by anti-CD3 antibody in humans. , 2008, Journal of autoimmunity.

[17]  Peter Libby,et al.  Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. , 2007, The Journal of clinical investigation.

[18]  M. Daemen,et al.  Cathepsin cysteine proteases in cardiovascular disease , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  V. Turk,et al.  Lysosomal cysteine cathepsins: signaling pathways in apoptosis , 2007, Biological chemistry.

[20]  D. Maurice,et al.  Formation of Extracellular Matrix-Digesting Invadopodia by Primary Aortic Smooth Muscle Cells , 2007, Circulation research.

[21]  E. Choke,et al.  Increased Angiogenesis at the Site of Abdominal Aortic Aneurysm Rupture , 2006, Annals of the New York Academy of Sciences.

[22]  G. Sukhova,et al.  Do Cathepsins Play a Role in Abdominal Aortic Aneurysm Pathogenesis? , 2006, Annals of the New York Academy of Sciences.

[23]  E. Choke,et al.  Abdominal Aortic Aneurysm Rupture Is Associated With Increased Medial Neovascularization and Overexpression of Proangiogenic Cytokines , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Isobe,et al.  Pioglitazone Prevents Acute and Chronic Cardiac Allograft Rejection , 2006, Circulation.

[25]  Peter Libby,et al.  Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Kos,et al.  Intracellular proteolytic activity of cathepsin B is associated with capillary‐like tube formation by endothelial cells in vitro , 2006, Journal of cellular biochemistry.

[27]  D. Watkins,et al.  Destabilizing Role of Cathepsin S in Murine Atherosclerotic Plaques , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[28]  R. Kalluri,et al.  Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors* , 2006, Journal of Biological Chemistry.

[29]  T. Welte,et al.  Cathepsin-regulated apoptosis , 2006, Apoptosis.

[30]  G. Dolganov,et al.  Comprehensive transcriptome of proteases and protease inhibitors in vascular cells. , 2006, Stroke.

[31]  D. Bandyk,et al.  An Overview of Matrix Metalloproteinases in the Pathogenesis and Treatment of Abdominal Aortic Aneurysms , 2005, Vascular and endovascular surgery.

[32]  M. Aoki,et al.  Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model , 2005, Gene Therapy.

[33]  R. Flavell,et al.  Role of Cathepsin S-Dependent Epithelial Cell Apoptosis in IFN-γ-Induced Alveolar Remodeling and Pulmonary Emphysema1 , 2005, The Journal of Immunology.

[34]  P. Libby,et al.  Cystatin C Deficiency Increases Elastic Lamina Degradation and Aortic Dilatation in Apolipoprotein E–Null Mice , 2005, Circulation research.

[35]  Gorav Ailawadi,et al.  Current concepts in the pathogenesis of abdominal aortic aneurysm. , 2003, Journal of vascular surgery.

[36]  P. Libby,et al.  Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth , 2003, Circulation research.

[37]  Makoto Naito,et al.  Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[38]  Alan Daugherty,et al.  Mechanisms of abdominal aortic aneurysm formation , 2002, Current atherosclerosis reports.

[39]  A Daugherty,et al.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.

[40]  S. Shapiro,et al.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.

[41]  G. Moneta,et al.  The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. , 2000, Archives of internal medicine.

[42]  N. Katunuma,et al.  Participation of a cathepsin L-type protease in the activation of caspase-3. , 1999, Cell structure and function.

[43]  P. Libby,et al.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms. , 1999, The Journal of clinical investigation.

[44]  G. Dranoff,et al.  Cathepsin S required for normal MHC class II peptide loading and germinal center development. , 1999, Immunity.

[45]  P. Libby,et al.  Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. , 1999, Circulation.

[46]  P. Libby,et al.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.

[47]  Y. Soini,et al.  Angiogenesis is associated with mononuclear inflammatory cells in abdominal aortic aneurysms. , 1998, Annales chirurgiae et gynaecologiae.

[48]  J. Curci,et al.  Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms , 1997, Coronary artery disease.

[49]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[50]  S. Lazarus,et al.  Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. , 1996, The Journal of clinical investigation.